-
Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation
21 May 2012
Amanda Robinson, Abby S. Van Voorhees, Sylvia Hsu, Neil J. Korman, Mark G. Lebwohl, Bruce F. Bebo, Robert E. Kalb
Background: A task force of the National Psoriasis Foundation Medical Board was convened to evaluate treatment options for pustular psoriasis. Meetings were held by teleconference. Consensus on treatm...
-
Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study
21 May 2012
Emily Y. Chu, Karolyn A. Wanat, Christopher J. Miller, Ravi K. Amaravadi, Leslie A. Fecher, Marcia S. Brose, Suzanne McGettigan, Lydia R. Giles, Lynn M. Schuchter, John T. Seykora, Misha Rosenbach
Background: Vemurafenib, a novel selective small molecule inhibitor of BRAF, has recently been shown to be effective in the treatment of melanomas harboring the BRAF V600E mutation. Similar to the bro...
-
Clinical and histopathologic spectrum of alopecia mucinosa/follicular mucinosis and its natural history in children
14 May 2012
Alex Zvulunov, Vered Shkalim, Dan Ben-Amitai, Meora Feinmesser
Background: Some authorities consider alopecia mucinosa (AM)/follicular mucinosis (FM) to invariably represent mycosis fungoides (MF). This understanding of AM/FM derives from observations in adults. ...
-
Germline melanoma susceptibility and prognostic genes: A review of the literature
14 May 2012
Katherine A. Ward, DeAnn Lazovich, Maria K. Hordinsky
In recent years, there have been increasing efforts to identify germline genetic variants that may alter melanoma susceptibility and prognosis. The findings of these studies have indicated the presenc...
-
Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment
10 May 2012
Giulio Fortuna, Nita Chainani-Wu, Francina Lozada-Nur, Massimo Aria, Rodrigo Cepeda-Valdes, Annamaria Pollio, M. Peter Marinkovich, Adriana E. Martinez-Salazar, Michele D. Mignogna, Anna L. Bruckner, Julio Cesar Salas-Alanís
Background: Epidermolysis bullosa (EB) is a genetic mucocutaneous disorder characterized by blister formation upon mild trauma. All 4 EB types may show oropharyngeal lesions involving either hard or s...
View More Articles in Press...